Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer
The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2011
by National Cancer Institute (NCI).
Recruitment status was Active, not recruiting
Study NCT01353300 Information provided by National Cancer Institute (NCI)
First Received on May 12, 2011. Last Updated on May 26, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hereditary Wilms Tumor
Kidney Cancer
Liver Cancer
Neuroblastoma
Pleuropulmonary Blastoma
Sarcoma
Additional conditions recognized in this trial
Carcinoma, Renal Cell
Central Nervous System Neoplasms
Kidney Neoplasms
Liver Neoplasms
Nervous System Neoplasms
Pulmonary Blastoma
Wilms Tumor
More general conditions related to this trial
Adenocarcinoma
Carcinoma
Digestive System Diseases
Digestive System Neoplasms
Genetic Diseases, Inborn
Kidney Diseases
Liver Diseases
Lung Neoplasms
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Complex and Mixed
Neoplasms, Connective and Soft Tissue
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Neoplastic Syndromes, Hereditary
Nervous System Diseases
Neuroectodermal Tumors
Neuroectodermal Tumors, Primitive
Neuroectodermal Tumors, Primitive, Peripheral
Respiratory Tract Neoplasms
Thoracic Neoplasms
Urogenital Neoplasms
Urologic Diseases
Urologic Neoplasms
Interventions listed in this trial
DNA analysis
cytogenetic analysis
gene expression analysis
gene rearrangement analysis
mutation analysis
polymerase chain reaction
polymorphism analysis
laboratory biomarker analysis
medical chart review
Sponsors listed in this trial
Children's Oncology Group
National Cancer Institute (NCI)
Back to top of Main Content
